Procaps Group S.A. (PROCF)

Market Cap	165.85M
Revenue (ttm)	414.10M
Net Income (ttm)	52.20M
Shares Out	112.82M
EPS (ttm)	0.52
PE Ratio	2.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,991
Open	1.470
Previous Close	1.470
Day's Range	1.470 - 1.470
52-Week Range	0.750 - 1.630
Beta	0.03
RSI	58.06
Earnings Date	May 2, 2025

About Procaps Group

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers ...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 5,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: PROCF